Vioxx Advisor

"Are You a Vioxx Victim?
It's Time to Find Expert Lawyers to Fight for You!"



December 1, 2009

National business news in brief | Treasury rates edge up; Vioxx arguments

Rates edge up The Treasury Department auctioned $30 billion in three-month bills on Monday at a discount rate of 0.060 percent, up from 0.040 percent last week. Another $31 billion in six-month bills was auctioned at a discount rate of 0.150 percent, up from 0.140 percent last week. Separately, the Federal Reserve said that the average yield for one-year Treasury bills fell to 0.27 percent last

More…

Merck backs a successor to Vioxx

Setting the stage for a scientific and regulatory battle, Merck says a large study has shown that a potential successor to its painkiller Vioxx is no more dangerous to the heart than an older painkiller still widely in use.

Click here for more info

Merck Weighing Options After Legal Setbacks in Vioxx Cases

Reacting to a couple of legal setbacks related to its embattled arthritis medication, Vioxx, U.S. drug manufacturer Merck & Co. said it is weighing legal options i

Link to original article

Doctor pleads guilty to health care fraud

BOSTON A Massachusetts doctor pleaded guilty to one count of health care fraud stemming from accusations that he faked research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. Dr. Scott Reuben, an anesthesiologist, also agreed to repay $361,932 of research grants... more...

Contact:

Copyright © 2005 Vioxx Advisor.com All Rights Reserved